Trunity Announces Update on Its Restructuring Plan

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Trunity Announces Update on Its Restructuring Plan

ATLANTA, GA and DAVIE, FL--(Marketwired - Dec 21, 2015) - Trunity Holdings, Inc. ( OTCQB : TNTY ) (the "Company") today announced an update on its planned restructuring to include the conversion of debt into shares, the spin out of its educational solutions business, and acquisition of Newco4pharmacy LLC ("N4P").

"We are thankful for the support of many of the legacy shareholders of the Company, and its debt holders. The response from our offer to convert debt into equity has been positive, and as a result, we have modified the original terms of our acquisition of Newco4pharmacy, LLC to further benefit the legacy shareholders, and debt holders who agreed to convert their debt," said Stephen Keaveney, the recently announced CEO of the public holding company.

The original terms of the December 9, 2015 Securities Exchange Agreement called for the N4P members to receive a newly issued Series X Preferred stock that converts to shares equal to 90% of the shares of common stock of the Company, the N4P members have now reduced the conversion amount to 85% and set the total number of common shares from the conversion at 10,000,000 shares. Further, a condition of the share agreement, that a minimum of 90% of the debt holders convert into common stock of the Company has been waived. At the time of the spin out, the Company expects that approximately $600,000 in debts will remain with the public holding company, as a result of the conversion of approximately $2.2 million, or 79%, of the holding company debts. In the Trunity, Inc., operating subsidiary, the debt holders have already converted approximately $400,000 of debt, or 35% of the total, and conversion efforts are ongoing.

The Company expects the final capital structure of the public holding company to be 11,765,000 shares outstanding upon completion of the restructuring, and conversion of the Series X Preferred stock issued to N4P members in the acquisition. Of the total, 10,000,000, or 85%, will be held by the N4P members, and the balance of 11,765,000 or 15% will be held by the legacy shareholders, and those debt holders who converted into common stock. This amounts to a reverse split for the legacy holders of 100.94 to one, such that a holder of 100.94 shares would have one share after the restructuring and spin out. Also all fractional shares will be rounded up to the next whole number of shares and the shares will be in addition to the 11,765,000 shares described herein.

"We are using our best efforts to complete the spin out of the educational solutions business before year end or early in the New Year, subject to regulatory approval. Ms. Nicole Fernandez-McGovern will continue to be the CEO of the private educational solutions business after the spin out," explained Keaveney. There will be 10,000,000 shares outstanding in the private company, an allocation of one share of the spin out for every 17.82 shares held in the public company, including all legacy shareholders, and those shares issued in the debt conversion effort, current and future. Also all fractional shares will be rounded up to the next whole number of shares and the shares will be in addition to the 10,000,000 shares described herein.

Subject to regulatory and shareholder approval, the restructured public company will be named True Nature Holdings, Inc., a Delaware "C" corporation and will consist of 500,000,000 authorized common shares, and 100,000,000 shares of preferred stock authorized. The Company expects that there will be 11,765,000 shares of common stock issued and outstanding as of the completion of the restructuring, and no shares of preferred stock issued.

The spin out company will be named Trunity, Inc., a Florida "C" corporation, and it will have 100,000,000 authorized common shares and 10,000,000 shares of preferred stock authorized. There will be 10,000,000 shares of common stock outstanding at the time of the spin out, and no preferred shares issued. Its offices are located at Davie, Florida.

Further details on the restructuring and spin out can be found in the Company's SEC filings, and http://www.sec.gov/cgi-bin/browse-edgar?actio...efilings=0

The Company has begun the regulatory approval process, and will continue to inform the shareholders of the status via press releases and further filings with the SEC.

FOR MORE INFORMATION ABOUT TRUNITY HOLDINGS TO BE KNOWN AS TRUE NATURE HOLDINGS, INC., PLEASE CONTACT: Stephen Keaveney Chief Executive Officer EMAIL: Email Contact 404-254-6980 FOR MORE INFORMATION ABOUT TRUNITY INC., THE SPIN OUT EDUCATION COMPANY CALL Ms. Nicole Fernandez-McGovern 866-723-4114

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 4

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading

Top 5 Most Recently Viewed Articles

SKK Holdings Limited Announces Pricing for Share IPO Offering

Updated Category News Views 65

SKK Holdings Limited Announces Share Pricing for IPO SKK Holdings Limited (“SKK” or the “Company”) (Nasdaq: SKK), a specialized civil engineering service provider in subsurface utility works, has proudly announced the pricing of its initial public offering. The Company will offer 2,500,000 ordinary shares at a public offering price of $4.00 per share, yielding...

Continue Reading
Antelope Enterprise: Financial Performance Insights for 2024

Updated Category News Views 149

Antelope Enterprise Holdings Limited (NASDAQ: AEHL) hit the financial report stage hard back in mid-2024, flaunting numbers that tell quite the tale of both triumphs and tribulations. This company was hustling across two growing fronts: the fast-paced world of livestreaming ecommerce and the burgeoning energy sector down in Texas. Their half-year performance review...

Continue Reading
Olivier Falut Steps Into CFO Role at EUROAPI to Drive Growth

Updated Category News Views 344

Olivier Falut Joins EUROAPI as the New Chief Financial Officer EUROAPI is excited to announce the appointment of Olivier Falut as its new Chief Financial Officer, effective immediately. Olivier will be an integral member of the Executive Committee, succeeding Evelyne Nguyen. Evelyne will ensure continuity and a smooth transition within the company through her support...

Continue Reading
OPEXUS and Casepoint Join Forces for Growth and Innovation

Updated Category News Views 261

OPEXUS and Casepoint Unite for Strategic Growth In a significant development in the technology sector, OPEXUS, a frontrunner in government process management software, and Casepoint, an innovator in data discovery technology, have announced their merger. This significant move comes along with a majority investment from Thoma Bravo, a renowned software investment firm...

Continue Reading
MeiraGTx Holdings: An In-Depth Look at Future Potential

Updated Category News Views 69

MeiraGTx Holdings plc (NASDAQ:MGTX) was a clinical-stage gene therapy firm making waves back in 2024. The company announced a pivotal financial move, securing $50 million through equity financing at $4 per share, largely thanks to a $30 million investment from Sanofi (NYSE:SNY). While this funding boosted MGTX’s war chest, traders were already whispering about the heavy...

Continue Reading